Position in RLAY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$13,058,607
-$5,893,774 QoQ
Shares Held
697,948
-63.4% QoQ
Ownership
0.318%
of shares outstanding
% of Portfolio
0.65%
of 13F equity value
Holder Rank
#52
of 258 holders
Holding Since
Sep 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RLAY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026EcoR1 Capital, LLC holds $1,935,887,028 across 29 Biotechnology names. RLAY ranks #17 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZYME |
Zymeworks Inc.
|
22,970,388 | $600,445,942 | |
| 2 | ANAB |
Anaptysbio, Inc
|
7,880,094 | $531,906,345 | |
| 3 | AKTS |
Aktis Oncology, Inc.
|
4,824,469 | $155,492,635 | |
| 4 | CGON |
CG Oncology, Inc.
|
1,494,300 | $106,170,015 | |
| 5 | CRSP |
CRISPR Therapeutics AG
|
1,389,276 | $75,771,113 | |
| 6 | ORIC |
Oric Pharmaceuticals, Inc.
|
6,728,116 | $72,865,496 | |
| 7 | TRAX |
First Tracks Biotherapeutics, Inc.
|
3,174,519 | $63,871,322 | |
| 8 | LKFT |
Lakefront Biotherapeutics NV
|
1,667,119 | $49,980,227 |
All Filings in RLAY
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,058,607 | 697,948 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $18,952,381 | 1,904,762 | Shares | Sole | 2026-05-15 | |
| 2025-03-31 | $1,680,536 | 641,426 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,642,675 | 641,426 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $17,700,000 | 2,500,000 | Shares | Sole | 2024-11-14 | |
| 2023-09-30 | $35,017,759 | 4,163,824 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $52,297,629 | 4,163,824 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $68,578,181 | 4,163,824 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $62,207,530 | 4,163,824 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $93,144,742 | 4,163,824 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $62,369,311 | 3,723,541 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $68,582,829 | 2,291,441 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $54,635,669 | 1,779,084 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $43,677,752 | 1,385,276 | Shares | Sole | 2021-11-22 | |
| 2021-06-30 | $164,207,723 | 4,487,776 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $118,553,078 | 3,429,363 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $133,018,972 | 3,200,649 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $136,315,640 | 3,200,649 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||